PharmExec

The Situation We Faced: Aaron Cowley, CSO, Recipharm Advanced Bio, Discusses Vision to Cut Biomanufacturing Timelines, Transform Continuous Manufacturing

The "Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century--A Risk Based Approach" initiative was ...
GEN - Genetic Engineering and Biotechnology News

An Agile, Intelligent and Sustainable Future: Biopharma Trends to Watch

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...
Star Tribune

3M spending $146M to expand biopharma filtration manufacturing

3M plans to invest $146 million to upgrade its biopharma filtration technology. The money will go toward facility improvements, equipment upgrades and the hiring of 60 full-time manufacturing ...
Business Wire

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug ...

DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...
Nasdaq

Aytu BioPharma Subleases a Portion of Its Manufacturing Facility

ENGLEWOOD, CO / ACCESSWIRE / May 1, 2023 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused ...
Nasdaq

Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing

Article describes Enteris' strengths and scalability in working with highly potent active pharmaceutical ingredients In the article, Mr. Consalvo discussed the skills necessary to work with HPAPIs, ...
Business Wire

KBI Biopharma Unveils KBI PUREplatform™, a Game-Changing Microbial Expression Offering to Redefine Biopharmaceutical Manufacturing

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of KBI PUREplatform™, a premium microbial cell line development (CLD) platform that ...